Fund Holdings — TPG GP A, LLC

Total Portfolio Value
$2.69B
Total Bought
$462.52M
Total Sold
$0
Net Transaction
+$462.52M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
BETA Technologies Inc016,395,435+16,395,4350462,51517.22%+462,515
LifeStance Health Group Inc(LFST)160,711,618160,711,6180883,9141,131,41042.11%+247,496
Sionna Therapeutics Inc(SION)6,744,9626,744,9620198,369277,48810.33%+79,118
CeriBell Inc.(CBLL)3,967,4223,967,422045,58687,0063.24%+41,420
Amneal Pharmaceuticals Inc(AMRX)12,328,76712,328,7670123,411155,3425.78%+31,932
Bicara Therapeutics Inc.3,010,4253,010,425047,53550,6651.89%+3,131
Allogene Therapeutics Inc18,716,30618,716,306023,20825,6410.95%+2,433
Rallybio Corp(RLYB)3,028,4143,028,41401,5142,0900.08%+575
TPG RE Fin Tr Inc(TRTX)2,392,8632,392,863020,48320,6030.77%+120
Life Time Group Holdings Inc(LTH)17,830,65217,830,6520492,126473,93917.64%-18,187
Page 1 of 1
TPG GP A, LLC — 13F Holdings — Q4 2025 | TickerTrail